🔗 Visit the ClinicalTrials.gov page for NCT00356629
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis. | J Pharmacol Exp Ther | 2006 | 0.90 |
| 2 | Characteristics of EPI-hNE4 aerosol: a new elastase inhibitor for treatment of cystic fibrosis. | J Aerosol Med | 2003 | 0.78 |